Becker’s Hospital Review magazine has listed Scripps Health among the nation’s “100 Hospitals and Health Systems with Great Oncology Programs” in its recently released compilation of leading cancer care providers in the United States.
According to the health care industry trade publication, organizations included on the 2014 list are “leading the way in terms of quality of patient care, patient outcomes and research.” Becker’s noted Scripps’ advanced technology and integrated network of cancer care, which consistently provides the highest quality of patient care across the Scripps Health system.
“This recognition reflects the exceptional care being delivered to cancer patients at Scripps,” said Scripps Health President and CEO Chris Van Gorder. “Our patients have access to an outstanding team of highly experienced physicians and nurses, the latest technology, clinical trials and rehabilitation and support services, all organized in a coordinated system of care to benefit our patients.”
Scripps Health provides comprehensive cancer care at its five hospital campuses and various Scripps outpatient locations, under a coordinated network program called Scripps Cancer Care. Scripps was the first health system in California to earn network accreditation from the American College of Surgeons’ Commission on Cancer, a designation it has retained since 2008.
Scripps offers a wide range of advanced cancer treatment technologies and programs. It recently opened two regional cancer care facilities: the Scripps Proton Therapy Center in Mira Mesa and the Scripps Radiation Therapy Center in La Jolla. It also offers specialized breast care centers across the region; the San Diego Gamma Knife Center at Scripps Memorial Hospital La Jolla; minimally invasive surgery; and the region’s first blood and marrow transplantation program, where patient survival rates have doubled since its founding in 1980.
With more than 300 affiliated physicians, Scripps Cancer Care seeks to provide the best possible treatment and leading-edge research trials for patients by coordinating medical expertise in the areas of clinical cancer care, community outreach and clinical, translational and basic research.